Data / Form D filings / LB PHARMACEUTICALS INC
LB PHARMACEUTICALS INC: Form D filings
LB PHARMACEUTICALS INC, a pharmaceuticals company in New York, NY, filed 11 Form D notices with the SEC between 2016 and 2024. The latest, on January 10, 2024, reports $110.7 million sold of a $110.7 million offering to 6 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 575 MADISON AVENUE, New York, NY, 10022
- Phone
- (212) 605-0230
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1691082
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jan 10, 2024 | Amendment | $110,730,354 | $110,730,354 | 6 | Aug 29, 2023 | sec.gov | |
| Sep 21, 2023 | New notice | $110,730,354 | $70,730,354 | $40,000,000 | 6 | Aug 29, 2023 | sec.gov |
| Nov 23, 2022 | Amendment | $40,000,000 | $16,574,000 | $23,426,000 | 71 | Oct 21, 2022 | sec.gov |
| Nov 1, 2022 | New notice | $10,000,000 | $6,925,000 | $3,075,000 | 21 | Oct 21, 2022 | sec.gov |
| Jul 6, 2022 | New notice | Indefinite | $903,350 | 35 | May 3, 2022 | sec.gov | |
| Sep 1, 2020 | New notice | $10,000,000 | $4,629,200 | $5,370,800 | 35 | Aug 18, 2020 | sec.gov |
| Dec 12, 2018 | New notice | $10,000,000 | $6,326,835 | $3,673,165 | 74 | Nov 21, 2018 | sec.gov |
| Aug 27, 2018 | New notice | $443,200 | $443,200 | 7 | Dec 20, 2017 | sec.gov | |
| May 29, 2018 | New notice | $750,000 | $330,000 | $420,000 | 11 | May 3, 2018 | sec.gov |
| Apr 6, 2017 | New notice | $462,000 | $462,000 | 8 | Apr 5, 2017 | sec.gov | |
| Dec 15, 2016 | New notice | $1,000,000 | $968,945 | $31,055 | 13 | Nov 25, 2016 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Rajul Jain | Director | |
| Ran Nussbaum | Director | |
| Zachary Prensky | Executive Officer, Director | |
| Robert Ruffolo | Director | |
| Andrew Vaino | Executive Officer | |
| Anna Eramo | Executive Officer | |
| Marc Panoff | Executive Officer | |
| Rebecca Luse | Director | |
| Chen Yu | Director |
Other pharmaceuticals companies in New York that filed recently
- Pierrepont Therapeutics, Inc. $2.4 million · Sep 22, 2026
Every Form D from the week of Jan 8, 2024 · All recent filings in New York · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what LB PHARMACEUTICALS INC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.